Research Article
The Prognostic Value of Lymph Node Cross-Sectional Cancer Area in Node-Positive Breast Cancer: A Comparison with N Stage and Lymph Node Ratio
Table 2
Prognostic factors and overall survival rate (univariate analysis by Kaplan-Meier).
| | 5-year OS% ± SE | value |
| Age | | | ≤50 | 84 ± 4 | 0.6
| >50 | 82 ± 2 | Histologic grade | | | G1 | 90 ± 5 | | G2 | 89 ± 3 | 0.001 | G3 | 73 ± 4 | | N stage | | | N0 | 94 ± 2 | | N1 | 86 ± 4 | <0.0001 | N2 | 53 ± 10 | N3 | 46 ± 12 | | T stage | | | T1 | 92 ± 2 | | T2 | 84 ± 36 | <0.0001
| T3 | 43 ± 13 | T4 | 36 ± 12 | | ER | | | Yes | 89 ± 2 | <0.0001
| No | 62 ± 6 | ECE | | | Yes | 93 ± 20 | <0.0001
| No | 63 ± 6 | LN CSCA (mm2) | | | 0 (N0) | 94 ± 22 | | <50 | 85 ± 54 | <0.0001
| 50–500 | 65 ± 7 | >500 | 46 ± 13 | | LNR | | | 0 (N0) | 94 ± 22 | | <0.1 | 90 ± 4 | <0.0001
| 0.1–0.65 | 79 ± 5 | >0.65 | 28 ± 10 | |
|
|